☰

Roberto B Salgado, Ph.D. - Publications

Affiliations: 
 
Area:
relativity, computation, pedagogy
Tree Info Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Leon-Ferre RA, Jonas SF, Salgado R, Loi S, de Jong V, Carter JM, Nielsen TO, Leung S, Riaz N, Chia S, Jules-Clément G, Curigliano G, Criscitiello C, Cockenpot V, Lambertini M, et al. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer. Jama. 331: 1135-1144. PMID 38563834 DOI: 10.1001/jama.2024.3056  0.371
2024 Rayson VC, Harris MA, Savas P, Hun ML, Virassamy B, Salgado R, Loi S. The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments. Trends in Cancer. PMID 38521654 DOI: 10.1016/j.trecan.2024.02.008  0.32
2024 Martín M, Yoder R, Salgado R, Del Monte-Millán M, Alvarez EL, Echavarría I, Staley JM, O'Dea AP, Nye LE, Stecklein SR, Bueno Muiño C, Jerez-Gilarranz Y, Cebollero M, Bueno O, Garcia-Saenz JÁ, et al. Tumor-infiltrating lymphocytes refine outcomes in triple-negative breast cancer treated with anthracycline-free neoadjuvant chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38466643 DOI: 10.1158/1078-0432.CCR-24-0106  0.318
2024 Ly A, Garcia V, Blenman KRM, Ehinger A, Elfer K, Hanna MG, Li X, Peeters DJE, Birmingham R, Dudgeon S, Gardecki E, Gupta R, Lennerz J, Pan T, Saltz J, ... ... Salgado R, et al. Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research. Histopathology. PMID 38433289 DOI: 10.1111/his.15140  0.323
2023 Sharma P, Stecklein SR, Yoder R, Staley JM, Schwensen K, O'Dea A, Nye L, Satelli D, Crane G, Madan R, O'Neil MF, Wagner J, Larson KE, Balanoff C, Kilgore L, ... ... Salgado R, et al. Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial. Jama Oncology. PMID 37991778 DOI: 10.1001/jamaoncol.2023.5033  0.342
2023 Rediti M, Fernandez-Martinez A, Venet D, Rothé F, Hoadley KA, Parker JS, Singh B, Campbell JD, Ballman KV, Hillman DW, Winer EP, El-Abed S, Piccart M, Di Cosimo S, Symmans WF, ... ... Salgado R, et al. Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials. Nature Communications. 14: 7053. PMID 37923752 DOI: 10.1038/s41467-023-42635-2  0.368
2023 Martins-Branco D, Nader-Marta G, Molinelli C, Ameye L, Paesmans M, Ignatiadis M, Aftimos P, Salgado R, de Azambuja E. Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis. European Journal of Cancer (Oxford, England : 1990). 194: 113358. PMID 37857118 DOI: 10.1016/j.ejca.2023.113358  0.314
2023 Steenbruggen TG, Wolf DM, Thijssen B, Sanders J, Cornelissen S, Salgado R, Mittempergher L, Bhaskaran R, Broeks A, Lips EH, Siesling S, Sonke GS, Horlings HM, van 't Veer LJ. Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort. Jco Precision Oncology. 7: e2200670. PMID 37738542 DOI: 10.1200/PO.22.00670  0.311
2023 Thagaard J, Broeckx G, Page DB, Jahangir CA, Verbandt S, Kos Z, Gupta R, Khiroya R, Abduljabbar K, Acosta Haab G, Acs B, Akturk G, Almeida JS, Alvarado-Cabrero I, Amgad M, ... ... Salgado R, et al. Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group. The Journal of Pathology. PMID 37608772 DOI: 10.1002/path.6155  0.368
2023 Machiels M, Oulkadi R, Tramm T, Stecklein SR, Somaiah N, De Caluwé A, Klein J, Tran WT, Salgado R. Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers. Breast (Edinburgh, Scotland). 71: 13-21. PMID 37437386 DOI: 10.1016/j.breast.2023.06.010  0.31
2023 Bergin ART, Salgado R, Loi S. Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status. Cancer Immunology Research. 11: 705-706. PMID 37264817 DOI: 10.1158/2326-6066.CIR-23-0323  0.31
2023 Bergin ART, Salgado R, Loi S. Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status. Cancer Immunology Research. 11: 705-706. PMID 37264817 DOI: 10.1158/2326-6066.CIR-23-0323  0.31
2023 Verghese G, Li M, Liu F, Lohan A, Kurian NC, Meena S, Gazinska P, Shah A, Oozeer A, Chan T, Opdam M, Linn S, Gillett C, Alberts E, Hardiman T, ... ... Salgado R, et al. Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies. The Journal of Pathology. PMID 37230111 DOI: 10.1002/path.6088  0.305
2023 Loi S, Salgado R, Schmid P, Cortes J, Cescon DW, Winer EP, Toppmeyer DL, Rugo HS, De Laurentiis M, Nanda R, Iwata H, Awada A, Tan AR, Sun Y, Karantza V, et al. Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. Jco Precision Oncology. 7: e2200317. PMID 37099733 DOI: 10.1200/PO.22.00317  0.314
2023 Voorwerk L, Isaeva OI, Horlings HM, Balduzzi S, Chelushkin M, Bakker NAM, Champanhet E, Garner H, Sikorska K, Loo CE, Kemper I, Mandjes IAM, de Maaker M, van Geel JJL, Boers J, ... ... Salgado R, et al. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial. Nature Cancer. 4: 535-549. PMID 37038006 DOI: 10.1038/s43018-023-00542-x  0.313
2023 Sayed S, Koka H, Abubakar M, Gardner K, Salgado R, Moloo Z, Caban-Ureña AB, Rosen D, Castro P, Saleh M, Shaikh AJ, Shah J, Figueroa J, Makokha F, Ha HK, et al. Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics. Breast Cancer Research and Treatment. PMID 37010652 DOI: 10.1007/s10549-023-06921-3  0.304
2022 Jimeno R, Mouron S, Salgado R, Loi S, Pérez-Mies B, Sánchez-Bayona R, Manso L, Martínez M, Garrido-García A, Serrano-Pardo R, Colomer R, Quintela-Fandino M. Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. PMID 36508123 DOI: 10.1007/s12094-022-03006-3  0.32
2022 Mercan C, Balkenhol M, Salgado R, Sherman M, Vielh P, Vreuls W, Polónia A, Horlings HM, Weichert W, Carter JM, Bult P, Christgen M, Denkert C, van de Vijver K, Bokhorst JM, et al. Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer. Npj Breast Cancer. 8: 120. PMID 36347887 DOI: 10.1038/s41523-022-00488-w  0.321
2022 Gazinska P, Milton C, Iacovacci J, Ward J, Buus R, Alaguthurai T, Graham R, Akarca A, Lips E, Naidoo K, Wesseling J, Marafioti T, Cheang M, Gillett C, Wu Y, ... ... Salgado R, et al. Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF15. PMID 36161312 DOI: 10.1158/1078-0432.CCR-22-0543  0.343
2022 Wall I, Boulat V, Shah A, Blenman KRM, Wu Y, Alberts E, Calado DP, Salgado R, Grigoriadis A. Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood. Cancers. 14. PMID 36139665 DOI: 10.3390/cancers14184505  0.331
2022 Baez-Navarro X, Salgado R, Denkert C, Lennerz JK, Penault-Llorca F, Viale G, Bartlett JMS, van Deurzen CHM. Selecting patients with HER2-low breast cancer: Getting out of the tangle. European Journal of Cancer (Oxford, England : 1990). 175: 187-192. PMID 36137393 DOI: 10.1016/j.ejca.2022.08.022  0.333
2022 Sugie T, Salgado R, Fong L. Editorial: Advancements in immunology and immunotherapy for breast cancer. Frontiers in Oncology. 12: 979806. PMID 36016626 DOI: 10.3389/fonc.2022.979806  0.354
2002 Salgado RB. Some Identities For The Quantum Measure And Its Generalizations Modern Physics Letters A. 17: 711-728. DOI: 10.1142/S0217732302007041  0.251
Show low-probability matches.